NextGenPCR® | From hours to minutes | High throughput | Any assay

News by MBS (NextGenPCR®)

Implementing fast, accessible viral surveillance with nanopore sequencing

Missed the webinar? Don’t worry you can watch it here.

Missed the webinar, where Matthijs Welkers and Ingra Morales Claro shared their experiences in developing and implementing fast and accessible pathogen surveillance protocols with nanopore sequencing using the NextgenPCR®?

The talk is now available , so you can catch up whenever suits you, or share with a colleague on demand

Webinar November 15, 2022

  • How to perform rapid targeted genome sequencing for surveillance of viral pathogens such as SARS-CoV-2 and monkeypox virus
  • Why microbiologists around the world are leveraging nanopore sequencing technology for infectious disease and public health applications
  • How to perform viral metagenomic sequencing for the genomic characterization of known and novel viruses in an untargeted manner

Over recent years, genomic sequencing of pathogens has emerged as a powerful tool to guide public health action by providing a deeper understanding of pathogen evolution, emerging variants and transmission dynamics. Oxford Nanopore Technologies offers an accessible, all-in-one sequencing platform that enables rapid, distributed and scalable genomic pathogen surveillance.

In this webinar, you will hear from leaders in the field of microbiology and infectious disease research, who will share their experiences in developing and implementing fast and accessible pathogen surveillance protocols with nanopore sequencing. The protocols presented in this webinar can be leveraged for targeted whole genome sequencing of different viral pathogens such as SARS-CoV-2 and monkeypox virus, as well as more broadly for the genomic characterization of known and novel viruses in an untargeted manner.

 

Speaker Information:

Dr. Matthijs Welkers
Medical Microbiologist
Amsterdam University Medical Centre

 

Dr. Ingra Morales Claro
Postdoctoral Research Associate
MRC Centre for Global Infectious Disease Analysis, Imperial College London

30 November 2022